Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Management of Hepatic Granulomatous Tuberculosis After Bcg Therapy for Bladder Cancer Publisher



Ayati M1 ; Nowroozi MR1 ; Mortazavi A1 ; Ohadian Moghadam S1 ; Ghorani H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Urology Case Reports Published:2017


Abstract

BCG therapy is used as a treatment in bladder cancer. Intravesical administration of Bacillus Calmette-Guerin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. He was treated successfully with antitubercular therapy and prednisolone. © 2017 The Authors